SBIR Phase II Grant Awarded for Next Generation NPWT and Delivery Platform




April 4, 2015
Newton, Massachusetts

Applied Tissue Technologies has been awarded a Phase II SBIR grant to further investigate it’s next generation NPWT (negative pressure wound therapy) under contract # W81XWH-14-C-0015 and sponsored by the DHP/ Army.  Click to follow link to SBIR reference page.

The two year term of the grant will commence immediately, and involve a GLP porcine study, FDA clearance, and establishment of commercial readiness for market launch.

The platform technology eliminates the wound intermediary layer commonly presented as foam or gauze in competitors products, thus enabling virtually limitless configurations and powerful topical drug delivery capabilities.

Applied Tissue Technologies is interested in speaking with prospective partners with interest in being involved in Phase III with this DoD supported technology.

For further information about Applied Tissue Technologies or its products please contact:

Applied Tissue Technologies
Media Relations
275 Grove Street
Ste 2-400
Newton, MA 02466